| Literature DB >> 28588638 |
Yanfang Yang1, Guijun Zhang1, Qiyu Sun2, Liang Liu2, Hui Peng2, Jingjuan Wang1, Li Xiang1.
Abstract
Gancao-Ganjiang-Tang (GGT) is a traditional Chinese medicine (TCM) prescription and is a representative prescription for recuperating depleted Yang in Treatise on Febrile Diseases. The TCM theory believes that the efficacy of medicinal herbs is decided by the multicompounds which consist of different kinds of chemical constituents with bioactivities, but not by a monomeric constituent. From ancient times until today, GGT have 5 different kinds of compatibilities that can be verified. In this study, a HPLC-DAD method was established for the simultaneous determination of 8 compounds including 6-gingerol, 8-gingerol, 6-shogaol, liquiritin, liquiritigenin, isoliquiritin, isoliquiritigenin, and glycyrrhizic acid in the five GGT. The total contents of the 8 compounds in GGT varied from 555.56 to 956.33 μg/mL. The effects showed that the dosage and compatibility of medicinal herbs have influenced the content of chemical compounds of TCM prescription while the content of chemical compounds has acted on clinical efficacy. Quality evaluation and active essence screening of TCM (including single herb and prescription) should be based on the TCM theory and clinical effectiveness. The method was proven to be suitable for quality control of GGT.Entities:
Year: 2017 PMID: 28588638 PMCID: PMC5446862 DOI: 10.1155/2017/4703632
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Compatibility of medicines, dosage, and symptoms of GGT in different period.
| Reference | Period | Compatibility of TCM | Dosage | Symptoms |
|---|---|---|---|---|
| Shang-han-lun (GGT-1) | Han dynasty | Rhizoma Zingiberis (raw) and Radix Glycyrrhizae (stir-baked with honey) | 12 g, 6 g | Serious Yang deficiency syndrome |
|
| ||||
| Jin-kui-yao-lue (GGT-2) | Han dynasty | Rhizoma Zingiberis (stir-baked) and Radix Glycyrrhizae (stir-baked with honey) | 12 g, 6 g | Relatively mild lung deficiency |
|
| ||||
| Ren-zhai-zhi-zhi-fang-lun (GGT-3) | Song dynasty | Rhizoma Zingiberis (stir-baked) and Radix Glycyrrhizae (stir-baked with honey) | 9 g, 9 g | Failure of spleen to control circulating blood caused by spleen-Yang deficiency |
|
| ||||
| Xue-lun-zheng (GGT-4) | Qing dynasty | Rhizoma Zingiberis (stir-baked), Radix Glycyrrhizae (stir-baked with honey), and Schisandrae Chinensis Fructus (raw) | 15 g, 6 g, 3 g | A variety of hernia symptoms and diarrhea |
|
| ||||
| Shan-qi-zheng-zhi-lun (GGT-5) | Meiji restoration period (Japan) | Rhizoma Zingiberis (raw), Radix Glycyrrhizae (raw), Fructus Zanthoxyli (raw), and Aconiti Lateralis Radix Praeparata | 15 g, 15 g, 9 g, 9 g | Blood syndromes |
The binary gradient elution system.
| Time (min) | 0~5 | 5~10 | 10~15 | 15~30 | 30~32 | 32~35 | 35~40 | 40~45 |
| A: acetonitrile (%) | 5~15 | 15~22 | 22~26 | 26~28 | 28~55 | 55~60 | 60~63 | 63~65 |
Detection wavelengths.
| Wavelengths (nm) | 235 nm | 254 nm | 280 nm | 370 nm |
| Compounds | Liquiritin | Glycyrrhizic acid | 6-Gingerol | Isoliquiritin |
Figure 1HPLC chromatograms of standard mixture (a), GGT test sample (b), test sample without Radix Glycyrrhizae (stir-baked with honey) (c), and test sample without Rhizoma Zingiberis (d). (1) Liquiritin, (2) isoliquiritin, (3) liquiritigenin, (4) glycyrrhizic acid, (5) isoliquiritigenin, (6) 6-gingerol, (7) 8-gingerol, and (8) 6-shogaol.
Linear regression equation, linear range, LOD, and LOQ for eight standard substances.
| Standard substance | Regression equation | Correlation coefficient ( | Linear range ( | LOD ( | LOQ ( |
|---|---|---|---|---|---|
| Liquiritin |
| 0.9998 | 18.5~296 | 1.52 | 4.56 |
| Isoliquiritin |
| 0.9999 | 7.9688~127.5 | 0.512 | 1.536 |
| Liquiritigenin |
| 0.9997 | 5.0625~81 | 0.477 | 1.431 |
| Glycyrrhizic acid |
| 0.9998 | 69.375~1110 | 2.561 | 7.683 |
| Isoliquiritigenin |
| 0.9997 | 0.9625~77 | 0.193 | 0.574 |
| 6-gingerol |
| 0.9995 | 10.625~170 | 1.847 | 5.541 |
| 8-Gingerol |
| 0.9997 | 5.4375~87 | 1.013 | 3.039 |
| 6-Shogaol |
| 0.9996 | 0.75~96 | 0.132 | 0.396 |
Precision, repeatability, stability, and recovery of eight substances.
| Compound | Precision | Repeatability | Stability | Recoveries (%) | |
|---|---|---|---|---|---|
| ( | RSD (%) | ||||
| Liquiritin | 0.88 | 1.36 | 0.51 | 99.89 | 1.58 |
| Isoliquiritin | 1.02 | 1.19 | 0.79 | 101.67 | 1.28 |
| Liquiritigenin | 1.73 | 0.97 | 1.32 | 98.93 | 1.33 |
| Glycyrrhizic acid | 0.99 | 1.82 | 0.33 | 100.87 | 0.97 |
| Isoliquiritigenin | 1.67 | 1.01 | 0.95 | 101.26 | 2.87 |
| 6-Gingerol | 1.58 | 1.96 | 2.11 | 99.94 | 1.45 |
| 8-Gingerol | 1.29 | 1.49 | 1.46 | 100.74 | 1.76 |
| 6-Shogaol | 1.42 | 2.01 | 0.72 | 98.75 | 2.83 |
Recovery (%) = 100 ∗ (amount found − original amount)/amount spiked.
The contents of eight compounds in GGT (n = 6).
| Compound |
| ||||
|---|---|---|---|---|---|
| GGT-1 | GGT-2 | GGT-3 | GGT-4 | GGT-5 | |
| Liquiritin | 175.68 ± 0.932 | 243.14 ± 0.699 | 151.42 ± 0.865 | 229.05 ± 0.829 | 144.81 ± 0.687 |
| Isoliquiritin | 20.23 ± 0.305 | 29.87 ± 0.108 | 17.45 ± 0.092 | 28.06 ± 0.42 | 15.96 ± 0.212 |
| Liquiritigenin | 10.87 ± 0.068 | 14.97 ± 0.163 | 8.92 ± 0.053 | 10.28 ± 0.114 | 11.23 ± 0.086 |
| Glycyrrhizic acid | 367.79 ± 0.987 | 624.53 ± 0.997 | 344.03 ± 1.212 | 391.56 ± 1.632 | 366.93 ± 1.230 |
| Isoliquiritigenin | 1.99 ± 0.018 | 3.29 ± 0.012 | 1.52 ± 0.031 | 2.23 ± 0.011 | 1.86 ± 0.045 |
| 6-Gingerol | 29.48 ± 0.114 | 22.42 ± 0.242 | 24.21 ± 0.346 | 17.99 ± 0.068 | 40.89 ± 0.920 |
| 8-Gingerol | 9.93 ± 0.034 | 14.97 ± 0.162 | 7.17 ± 0.049 | 10.89 ± 0.052 | 11.07 ± 0.058 |
| 6-Shogaol | 4.88 ± 0.029 | 3.14 ± 0.022 | 0.84 ± 0.015 | 0.97 ± 0.014 | 1.29 ± 0.011 |
| Total content of eight compounds | 620.85 ± 1.42 | 956.33 ± 2.744 | 555.56 ± 1.23 | 691.03 ± 3.232 | 594.04 ± 3.41 |
Compared with GGT-2, P < 0.05.
Figure 2The contents of eight compounds in GGT (μg/mL) (n = 3).
Figure 3Correlation between symptoms and content of GGT-1 and GGT-2.
Figure 4Correlation between symptoms and content of GGT-4 and GGT-5.
Figure 5Correlation between symptoms and content of GGT-3.